
Tayyab Shah
@tayyabshahmd
Cardiology Fellow, Outcomes Researcher
ID: 1893790435862007808
23-02-2025 22:30:06
5 Tweet
7 Followers
62 Following

📖Network metaanalysis for #endovascular intrvntions in #SFA disease. Newer endovascular techniques were superior to PTA regarding technical success, primary patency at 12m & symptom improvement #PAD doi.org/10.1016/j.jsca… Alexandra Lansky Sahil A. Parikh, MD Jay Giri @ACFanaroff


Excited to share the culmination of two years of work. Yale Cardiovascular Research Group Yale Cardiology Penn Cardiology Fellows Penn Cardiology


🚨#SFA study of 57 trials & 9089 pts compared 9 treatments for Superficial Femoral Artery disease💡 @SahilParikhMD Khanjan Shah & AndrewSchwartz break down the study in this interview🎥 ➡️youtu.be/uO9-6uTUH2w 📖Read the article: doi.org/10.1016/j.jsca…



🏅Our Mason-Sones Distinguished Service Award goes to Alexandra Lansky and Timothy Henry for their notable contributions to our mission! #SCAI2025 Yale Interventional Cardiology


Thank you SCAI for the opportunity to present our preliminary results on microcirculation effects of Impella 5.5! Full support microaxial flow pump improves microvascular hemodynamics Joyce Wald John Greenwood Navin Kapur Johnson & Johnson MedTech | Heart Recovery




🆕 meta-analysis: Early aortic valve replacement before severe symptomatic AS shows no significant benefit for most hard endpoints like mortality or MI but may reduce stroke. ow.ly/9cBp50W0VMB Tayyab Shah Alexandra Lansky Jeffrey Popma



Renal denervation for HTN was approved the FDA over 18 months ago. But very few cases performed in the US despite a theoretical eligible population >100M patients for this therapy. We cover the elephant in the room: reimbursement in Cardiac Interventions Today. citoday.com/articles/2025-…